Here are five things to know:
1. Nine ratings firms covering AmSurg stock provided the “buy ” rating.
2. Christopher Holden, CEO of AmSurg, sold 3,000 shares of stock on June 3.
3. Shares were sold at an average price of $60.09 for a total transaction worth $207,060.
4. AmSurg shares traded up 0.23 percent last Thursday, reaching $70.36.
5. The stock has a 50-day moving average of $69.27 and a 200-day moving average of $61.66. The market cap is $3.35 billion.
For more ASC news:
38 spine-driven ASCs to know | 2015
Go beyond analytics: How business intelligence can make ASCs more money (Part 2)
Opportunities during times of change: Key strategies for orthopedic centers
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
